496 related articles for article (PubMed ID: 33632305)
1. Inhibition of miR-199a-5p rejuvenates aged mesenchymal stem cells derived from patients with idiopathic pulmonary fibrosis and improves their therapeutic efficacy in experimental pulmonary fibrosis.
Shi L; Han Q; Hong Y; Li W; Gong G; Cui J; Mao M; Liang X; Hu B; Li X; Luo Q; Zhang Y
Stem Cell Res Ther; 2021 Feb; 12(1):147. PubMed ID: 33632305
[TBL] [Abstract][Full Text] [Related]
2. miR-155-5p inhibition rejuvenates aged mesenchymal stem cells and enhances cardioprotection following infarction.
Hong Y; He H; Jiang G; Zhang H; Tao W; Ding Y; Yuan D; Liu J; Fan H; Lin F; Liang X; Li X; Zhang Y
Aging Cell; 2020 Apr; 19(4):e13128. PubMed ID: 32196916
[TBL] [Abstract][Full Text] [Related]
3. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.
Cheng T; Ding S; Liu S; Li Y; Sun L
Theranostics; 2021; 11(2):893-905. PubMed ID: 33391511
[No Abstract] [Full Text] [Related]
4. Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis.
Cárdenes N; Álvarez D; Sellarés J; Peng Y; Corey C; Wecht S; Nouraie SM; Shanker S; Sembrat J; Bueno M; Shiva S; Mora AL; Rojas M
Stem Cell Res Ther; 2018 Sep; 9(1):257. PubMed ID: 30257725
[TBL] [Abstract][Full Text] [Related]
5. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1.
Lino Cardenas CL; Henaoui IS; Courcot E; Roderburg C; Cauffiez C; Aubert S; Copin MC; Wallaert B; Glowacki F; Dewaeles E; Milosevic J; Maurizio J; Tedrow J; Marcet B; Lo-Guidice JM; Kaminski N; Barbry P; Luedde T; Perrais M; Mari B; Pottier N
PLoS Genet; 2013; 9(2):e1003291. PubMed ID: 23459460
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic preconditioning rejuvenates mesenchymal stem cells and enhances neuroprotection following intracerebral hemorrhage via the miR-326-mediated autophagy.
Liu J; He J; Ge L; Xiao H; Huang Y; Zeng L; Jiang Z; Lu M; Hu Z
Stem Cell Res Ther; 2021 Jul; 12(1):413. PubMed ID: 34294127
[TBL] [Abstract][Full Text] [Related]
7. CDKN2B antisense RNA 1 expression alleviates idiopathic pulmonary fibrosis by functioning as a competing endogenouse RNA through the miR-199a-5p/Sestrin-2 axis.
Yang M; Yin E; Xu Y; Liu Y; Li T; Dong Z; Tai W
Bioengineered; 2022 Mar; 13(3):7746-7759. PubMed ID: 35291918
[TBL] [Abstract][Full Text] [Related]
8. Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis.
Zhao X; Wu J; Yuan R; Li Y; Yang Q; Wu B; Zhai X; Wang J; Magalon J; Sabatier F; Daumas A; Zhu WM; Zhu N
Sci Rep; 2023 Aug; 13(1):13183. PubMed ID: 37580529
[TBL] [Abstract][Full Text] [Related]
9. MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway.
Zhang F; Gao F; Wang K; Liu X; Zhang Z
Stem Cell Res Ther; 2021 Feb; 12(1):115. PubMed ID: 33546760
[TBL] [Abstract][Full Text] [Related]
10. Hemin enhances the cardioprotective effects of mesenchymal stem cell-derived exosomes against infarction via amelioration of cardiomyocyte senescence.
Zheng H; Liang X; Han Q; Shao Z; Zhang Y; Shi L; Hong Y; Li W; Mai C; Mo Q; Fu Q; Ma X; Lin F; Li M; Hu B; Li X; Zhang Y
J Nanobiotechnology; 2021 Oct; 19(1):332. PubMed ID: 34674708
[TBL] [Abstract][Full Text] [Related]
11. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
Yang G; Yang L; Wang W; Wang J; Wang J; Xu Z
Gene; 2015 May; 562(1):138-44. PubMed ID: 25725128
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-199a-5p aggravates angiotensin II-induced vascular smooth muscle cell senescence by targeting Sirtuin-1 in abdominal aortic aneurysm.
Tao W; Hong Y; He H; Han Q; Mao M; Hu B; Zhang H; Huang X; You W; Liang X; Zhang Y; Li X
J Cell Mol Med; 2021 Jul; 25(13):6056-6069. PubMed ID: 34132029
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of miR-34a reduces cellular senescence in human adipose tissue-derived mesenchymal stem cells through the activation of SIRT1.
Mokhberian N; Bolandi Z; Eftekhary M; Hashemi SM; Jajarmi V; Sharifi K; Ghanbarian H
Life Sci; 2020 Sep; 257():118055. PubMed ID: 32634429
[TBL] [Abstract][Full Text] [Related]
14. Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells.
Zhang F; Cui J; Liu X; Lv B; Liu X; Xie Z; Yu B
Stem Cell Res Ther; 2015 Oct; 6():195. PubMed ID: 26446137
[TBL] [Abstract][Full Text] [Related]
15. MiR-34a suppression targets Nampt to ameliorate bone marrow mesenchymal stem cell senescence by regulating NAD
Pi C; Ma C; Wang H; Sun H; Yu X; Gao X; Yang Y; Sun Y; Zhang H; Shi Y; Li Y; Li Y; He X
Stem Cell Res Ther; 2021 May; 12(1):271. PubMed ID: 33957971
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p.
Hou J; Wang L; Wu Q; Zheng G; Long H; Wu H; Zhou C; Guo T; Zhong T; Wang L; Chen X; Wang T
Stem Cell Res Ther; 2018 Apr; 9(1):109. PubMed ID: 29673400
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells-derived exosomes carrying microRNA-30b confer protection against pulmonary fibrosis by downregulating Runx1 via Spred2.
Zhu L; Xu Y; Wang J; Zhang Y; Zhou J; Wu H
Mol Genet Genomics; 2024 Mar; 299(1):33. PubMed ID: 38478174
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stromal cells attenuate alveolar type 2 cells senescence through regulating NAMPT-mediated NAD metabolism.
Lai X; Huang S; Lin S; Pu L; Wang Y; Lin Y; Huang W; Wang Z
Stem Cell Res Ther; 2022 Jan; 13(1):12. PubMed ID: 35012648
[TBL] [Abstract][Full Text] [Related]
19. Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients.
Atanasova E; Milosevic D; Bornschlegl S; Krucker KP; Jacob EK; Carmona Porquera EM; Anderson DK; Egan AM; Limper AH; Dietz AB
Stem Cell Res Ther; 2022 Jan; 13(1):45. PubMed ID: 35101101
[TBL] [Abstract][Full Text] [Related]
20. miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis.
Disayabutr S; Kim EK; Cha SI; Green G; Naikawadi RP; Jones KD; Golden JA; Schroeder A; Matthay MA; Kukreja J; Erle DJ; Collard HR; Wolters PJ
PLoS One; 2016; 11(6):e0158367. PubMed ID: 27362652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
